Literature DB >> 16474172

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.

Christopher S Carlson1, Patrick J Heagerty, Thomas S Hatsukami, Rebecca J Richter, Jane Ranchalis, Julieann Lewis, Tamara J Bacus, Laura A McKinstry, Gerard D Schellenberg, Mark Rieder, Deborah Nickerson, Clement E Furlong, Alan Chait, Gail P Jarvik.   

Abstract

Paraoxonase 1 (PON1) activity is consistently predictive of vascular disease, although the genotype at four functional PON1 polymorphisms is not. To address this inconsistency, we investigated the role of all common PON1 genetic variability, as measured by tagging single-nucleotide polymorphisms (tagSNPs), in predicting PON1 activity for phenylacetate hydrolysis, LDL susceptibility to oxidation ex vivo, plasma homocysteine (Hcy) levels, and carotid artery disease (CAAD) status. The biological goal was to establish whether additional common genetic variation beyond consideration of the four known functional SNPs improves prediction of these phenotypes. PON2 and PON3 tagSNPs were secondarily evaluated. Expanded analysis of an additional 26 tagSNPs found evidence of previously undescribed common PON1 polymorphisms that affect PON1 activity independently of the four known functional SNPs. PON1 activity was not significantly correlated with LDL oxidative susceptibility, but genotypes at the PON1(-108) promoter polymorphism and several other PON1 SNPs were. Neither PON1 activity nor PON1 genotype was significantly correlated with plasma Hcy levels. This study revealed previously undetected common functional PON1 polymorphisms that explain 4% of PON1 activity and a high rate of recombination in PON1, but the sum of the common PON1 locus variation does not explain the relationship between PON1 activity and CAAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474172     DOI: 10.1194/jlr.M500517-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  16 in total

1.  TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.

Authors:  Christopher S Carlson; Patrick J Heagerty; Alex S Nord; David K Pritchard; Jane Ranchalis; Joshua M Boguch; Hangjun Duan; Thomas S Hatsukami; Stephen M Schwartz; Mark J Rieder; Deborah A Nickerson; Gail P Jarvik
Journal:  Hum Genet       Date:  2006-11-18       Impact factor: 4.132

2.  Dietary cholesterol increases paraoxonase 1 enzyme activity.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Karen S Nakayama; Ella R Jarvik; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2012-08-15       Impact factor: 5.922

3.  Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.

Authors:  Sudeshna Dasgupta; F Yesim Demirci; Amy S Dressen; Amy H Kao; Elisa Y Rhew; Rosalind Ramsey-Goldman; Susan Manzi; Candace M Kammerer; M Ilyas Kamboh
Journal:  BMC Med Genet       Date:  2011-01-11       Impact factor: 2.103

4.  Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.

Authors:  Simon Cronin; Matthew J Greenway; Jochen H M Prehn; Orla Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

Review 5.  Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.

Authors:  Issa J Dahabreh; Georgios D Kitsios; David M Kent; Thomas A Trikalinos
Journal:  Genet Med       Date:  2010-10       Impact factor: 8.822

Review 6.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

7.  Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis.

Authors:  Stephan Riedmaier; Kathrin Klein; Stefan Winter; Ute Hofmann; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2011-07-27       Impact factor: 5.810

8.  Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Rebecca J Richter; Julieann K Marshall; Jason F Eintracht; Elisabeth A Rosenthal; Clement E Furlong; Gail P Jarvik
Journal:  J Lipids       Date:  2012-05-22

9.  Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates.

Authors:  Judit Marsillach; Rebecca J Richter; Lucio G Costa; Clement E Furlong
Journal:  Curr Protoc       Date:  2021-01

10.  Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.

Authors:  Philip W Connelly; Bernard Zinman; Graham F Maguire; Mary Mamakeesick; Stewart B Harris; Robert A Hegele; Ravi Retnakaran; Anthony J G Hanley
Journal:  J Lipid Res       Date:  2009-01-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.